乳腺癌女性的克隆性造血
本文综述多项研究数据,评估乳腺癌患者中克隆性造血(CH)的患病率、CH与细胞毒性治疗暴露的关系以及CH与乳腺癌特异性结局的相关性。结果显示CH在乳腺癌患者中常见,尤其在接受细胞毒性治疗者中,但无确切数据支持CH与乳腺癌特异性结局相关。当前数据不支持对乳腺癌患者常规进行CH检测,CH存在也不应影响大多数患者的乳腺癌治疗决策。
要点
- CH在乳腺癌患者中常见,尤其在接受细胞毒性治疗者中。
- 无确切数据支持CH与乳腺癌特异性结局相关。
- 当前数据不支持常规CH检测,CH存在不应影响大多数患者的治疗决策。
核心结论
- 当前数据不支持对乳腺癌患者常规进行CH检测,CH存在也不应影响大多数患者的乳腺癌治疗决策。
- 需要更大规模、长期的研究来进一步明确CH在乳腺癌患者中的意义并指导临床决策。
研究设计与样本
- 本文为综述,汇总多项研究的数据,包括一系列乳腺癌患者队列,以评估CH患病率、CH与细胞毒性治疗暴露的关系以及CH与乳腺癌特异性结局的相关性。
主要发现
- CH在乳腺癌患者中常见,尤其在接受细胞毒性治疗者中。
- 无确切数据支持CH存在与乳腺癌特异性结局相关。
临床怎么用
- 当前数据不支持对乳腺癌患者常规进行CH检测。
- CH存在不应影响大多数患者的乳腺癌治疗决策。
局限性
- 需要更大规模、长期的研究来进一步明确CH在乳腺癌患者中的意义并指导临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Clonal hematopoiesis (CH) has been associated with a variety of adverse outcomes, most notably hematologic malignancy and ischemic cardiovascular disease. A series of recent studies also suggest that CH may play a role in the outcomes of patients with solid tumors, including breast cancer. Here, we review the clinical and biological data that underlie potential connections between CH, inflammation, and breast cancer, with a focus on the prevalence and impact of clonal hematopoiesis of indeterminate potential in patients with breast cancer. METHODS: We summarize data from multiple studies, including a series of cohorts of patients with breast cancer, to assess the prevalence of CH, the relationship between CH and exposure to cytotoxic therapy, and the correlation between CH and breast cancer-specific outcomes. RESULTS: Our findings indicate that CH is prevalent among patients with breast cancer, particularly those treated with cytotoxic therapies. However, there are no definitive data to support an association between the presence of CH and breast cancer-specific outcomes. CONCLUSION: Current data do not support routine CH testing in patients with breast cancer, nor should the presence of CH influence decisions regarding breast cancer therapy in most patients. However, larger, long-term studies are necessary to further define the implications of CH in patients with breast cancer and guide clinical decision making.
引用
- Mayerhofer C, Freedman RA, Parsons HA, et al. Clonal Hematopoiesis in Women With Breast Cancer. J Clin Oncol. 2025. PMID: 39823557. doi:10.1200/JCO-24-01848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。